Concepedia

Carol S. Quagliato

CS

3

Publications

155

Citations

3

H-Index

1993

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Carol S. Quagliato is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, drug discovery, and medicine.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyMedicinal ChemistryMolecular PharmacologyBiomolecular EngineeringPhysiologyHypertensionDrug Development

Publications per year

1993–1993

3

Publications

3

A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor

Stephen E. de Laszlo, Carol S. Quagliato, William J. Greenlee et al. · Journal of Medicinal Chemistry · 1993 · 113 citations · Full text

Hypertension, Cardiovascular Pharmacology, Altmetric Attention Score +21

Quinazolinones 2: QSAR and in vivo characterization of AT1 selective AII antagonists

Stephen E. de Laszlo, E.E. Allen, Carol S. Quagliato et al. · Bioorganic & Medicinal Chemistry Letters · 1993 · 22 citations

Drug Target, Functional Selectivity, Medicine +8

Quinazolinones 1: design and synthesis of potent quinazolinone- containing AT1-selective angiotensin-II receptor antagonists

E.E. Allen, Stephen E. de Laszlo, Song X. Huang et al. · Bioorganic & Medicinal Chemistry Letters · 1993 · 20 citations

Molecular Pharmacology, Medicinal Chemistry, Functional Selectivity +8

Rows per page

1–3 of 3